Crucial Patents Could Mean Explosive Opportunity (ad) |
|
This P/L chart will make your eyes pop (ad) |
Today I want to show you how our research shows you could've grown a $25,000 account into $109,616.12 within the last TWO months.
You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists…
It's a revolutionary software system that tracks the moves of institutional investors…. in real time…
Go here to watch the most recent trading workshop video at no charge. |
|
- No Headlines, Ratings, Earnings Results, Dividends, Insider Trades, Options Activity, Company Press Releases or Headlines Today
- CEO Mark Zuckerberg sold 16,702 shares of the business's stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $533.24, for a total value of $8,906,174.48. Following the transaction, the chief executive officer now directly owns 28,838 shares in the company, valued at $15,377,575.12. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
- CEO Mark Zuckerberg sold 16,702 shares of the company's stock in a transaction on Monday, August 19th. The stock was sold at an average price of $526.94, for a total transaction of $8,800,951.88. Following the transaction, the chief executive officer now owns 46,292 shares of the company's stock, valued at approximately $24,393,106.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
- (8/22) Atria Wealth Solutions Inc. Raises Stake in Meta Platforms, Inc. (NASDAQ:META) (marketbeat.com)
- (8/22) Mark Zuckerberg Sells 16,702 Shares of Meta Platforms, Inc. (NASDAQ:META) Stock (insidertrades.com)
- (8/22) Chinese AI firms want to take on Meta's Ray-Ban smart glasses, prepare for gold rush in AI smart glasses (firstpost.com)
- (8/21) Lecap Asset Management Ltd. Makes New $907,000 Investment in Meta Platforms, Inc. (NASDAQ:META) (marketbeat.com)
- (8/21) Meta Platforms Is Embarking On A New Chapter – Consider METU Or METD (benzinga.com)
- (8/21) What Is Meta Platforms, Inc.'s (NASDAQ:META) Share Price Doing? (finance.yahoo.com)
- (8/21) Doximity: The 'Facebook for Doctors' Surges After Earnings Beat (META) (marketbeat.com)
- (8/21) Stock-Split Watch: 3 Artificial Intelligence (AI) Stocks That Look Ready to Split (fool.com)
- Bilibili (NASDAQ:BILI) was upgraded by analysts at Nomura from a "neutral" rating to a "buy" rating. They now have a $18.00 price target on the stock. This represents a 26.6% upside from the current price of $14.22.
- Crocs (NASDAQ:CROX) was upgraded by analysts at Williams Trading from a "hold" rating to a "buy" rating. They now have a $163.00 price target on the stock, up previously from $135.00. This represents a 13.5% upside from the current price of $143.62.
- EstΓ©e Lauder Companies (NYSE:EL) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $114.00 price target on the stock, up previously from $95.00. This represents a 22.7% upside from the current price of $92.89.
- Navigator (NYSE:NVGS) was upgraded by analysts at Clarkson Capital from a "neutral" rating to a "buy" rating. They now have a $20.00 price target on the stock. This represents a 22.2% upside from the current price of $16.36.
- SentinelOne (NYSE:S) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $29.00 price target on the stock, up previously from $19.00. This represents a 15.5% upside from the current price of $25.11.
- Unilever (NYSE:UL) was upgraded by analysts at Bank of America Co. from an "underperform" rating to a "buy" rating. They now have a $72.00 price target on the stock, up previously from $47.00. This represents a 14.9% upside from the current price of $62.66.
- Select Water Solutions (NYSE:WTTR) was upgraded by analysts at Northland Securities from a "market perform" rating to an "outperform" rating. They now have a $14.50 price target on the stock. This represents a 30.3% upside from the current price of $11.13.
- View today's most recent analysts' upgrades at MarketBeat.com
Wondering which AI stocks are set to soar in 2024? We've identified the top 3, and we're excited to share them with you! Unlock immediate access to our exclusive report and discover... the key players and strategic insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.
[Download Your Free Report Now] |
|
- Assurant (NYSE:AIZ) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $200.00 price target on the stock. This represents a 6.5% upside from the current price of $187.87.
- Goosehead Insurance (NASDAQ:GSHD) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating. They now have a $90.00 price target on the stock. This represents a 11.5% upside from the current price of $80.73.
- ItaΓΊ Unibanco (NYSE:ITUB) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.The current price is $6.61.
- Sprout Social (NASDAQ:SPT) was downgraded by analysts at KeyCorp from a "sector weight" rating to an "underweight" rating. They now have a $28.00 price target on the stock. This represents a 12.9% downside from the current price of $32.13.
- TJX Companies (NYSE:TJX) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $128.00 price target on the stock, up previously from $110.00. This represents a 6.0% upside from the current price of $120.70.
- Urban Outfitters (NASDAQ:URBN) was downgraded by analysts at Telsey Advisory Group from an "outperform" rating to a "market perform" rating. They now have a $44.00 price target on the stock, down previously from $49.00. This represents a 17.8% upside from the current price of $37.36.
- View today's most recent analysts' downgrades at MarketBeat.com
The asset beating inflation by 4x (ad) |
Central Bank Gold Heist In Progress
Central banks are buying gold at record rates... and billionaire investors are buying right along with them. Even Warren Buffett put over $500 million into gold. And with the help of a tax and penalty-free "Trump Loophole, " these investors are investing retirement into gold and other precious metals without having to put up any of their own cash. In our Free Retirement Protection Kit, we reveal all the details on how the rich use this loophole to protect and growth their retirement wealth in any economy…and show you how you can use it too.
Click here to get your free copy today. |
|
- Altus Midstream (NASDAQ:ALTM) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $3.00 price target on the stock. This represents a 4.2% upside from the current price of $2.88.
- BrightView (NYSE:BV) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $16.00 price target on the stock. This represents a 3.6% upside from the current price of $15.44.
- CubeSmart (NYSE:CUBE) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $53.00 price target on the stock. This represents a 6.2% upside from the current price of $49.90.
- Dada Nexus (NASDAQ:DADA) is now covered by analysts at Daiwa Capital Markets. They set a "neutral" rating on the stock.The current price is $1.30.
- Journey Medical (NASDAQ:DERM) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $9.00 price target on the stock. This represents a 96.9% upside from the current price of $4.57.
- Emergent BioSolutions (NYSE:EBS) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $16.00 price target on the stock. This represents a 60.6% upside from the current price of $9.96.
- EPAM Systems (NYSE:EPAM) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $204.00 price target on the stock. This represents a 1.7% upside from the current price of $200.50.
- FedEx (NYSE:FDX) is now covered by analysts at TD Cowen. They set a "buy" rating and a $334.00 price target on the stock. This represents a 14.7% upside from the current price of $291.21.
- Flutter Entertainment (NYSE:FLUT) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $247.00 price target on the stock. This represents a 17.4% upside from the current price of $210.42.
- Globant (NYSE:GLOB) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "hold" rating and a $210.00 price target on the stock. This represents a 2.7% upside from the current price of $204.49.
- Hims & Hers Health (NYSE:HIMS) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $24.00 price target on the stock. This represents a 42.9% upside from the current price of $16.80.
- INmune Bio (NASDAQ:INMB) is now covered by analysts at Scotiabank. They set a "sector outperform" rating and a $22.00 price target on the stock. This represents a 228.8% upside from the current price of $6.69.
- Disc Medicine (NASDAQ:IRON) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $75.00 price target on the stock. This represents a 52.3% upside from the current price of $49.26.
- Milestone Pharmaceuticals (NASDAQ:MIST) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $9.00 price target on the stock. This represents a 508.1% upside from the current price of $1.48.
- Orchestra BioMed (NASDAQ:OBIO) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $14.00 price target on the stock. This represents a 122.2% upside from the current price of $6.30.
- Palantir Technologies (NYSE:PLTR) is now covered by analysts at Northland Securities. They set a "market perform" rating and a $35.00 price target on the stock. This represents a 7.6% upside from the current price of $32.53.
- Tectonic Therapeutic (NASDAQ:TECX) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $55.00 price target on the stock. This represents a 230.1% upside from the current price of $16.66.
- Tandem Diabetes Care (NASDAQ:TNDM) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $45.00 price target on the stock. This represents a 6.2% upside from the current price of $42.39.
- Unity Biotechnology (NASDAQ:UBX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $8.00 price target on the stock. This represents a 411.2% upside from the current price of $1.57.
- United Parcel Service (NYSE:UPS) is now covered by analysts at TD Cowen. They set a "hold" rating on the stock.The current price is $126.88.
- UroGen Pharma (NASDAQ:URGN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $40.00 price target on the stock. This represents a 162.1% upside from the current price of $15.26.
- View today's most recent analysts' new coverage at MarketBeat.com
Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: |
| - Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. - Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. - Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| START YOUR 30-DAY FREE TRIAL |
|
Upgrade Your Subscription |
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW |
|
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO |
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
JOIN NOW |
|
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103 . United States. Today's Bonus Content: It's over. |
No comments:
Post a Comment